Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
481 to 500 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R01HL158097 | Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and Disease | 1 | 2024 |
| R01NS087635 | Signal Transduction by alphavbeta8 Integrin | 1 | 2024 |
| R21MH131740 | Molecular analysis of glutamatergic neurons derived from iPSCs containing PPM1D truncating mutations found in Jansen de Vries Syndrome | 1 | 2024 |
| R35CA232124 | Identifying Metabolic Dependencies of Pancreatic Cancers | 1 | 2024 |
| R35ES028365 | Developing Metabolomic Technologies to Advance Environmental Exposure Analysis | 1 | 2024 |
| R35HL144475 | Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis | 1 | 2024 |
| R35NS097370 | Functional roles of genetic risk factors for brain disorders in neurogenesis and neurodevelopment | 1 | 2024 |
| R37CA214679 | Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation | 1 | 2024 |
| R37CA226969 | Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer | 1 | 2024 |
| S10OD036427 | HIGH THROUGHPUT NGS SEQUENCER AT THE BCM GENOMIC AND RNA PROFILING CORE | 1 | 2024 |
| T32AI005284 | Integrative Immunology Training Grant | 1 | 2024 |
| T32AI007501 | Training in HIV/AIDS Pathogenesis; Basic and Translational Research | 1 | 2024 |
| T32CA009666 | Research Training in Academic Medical Oncology | 1 | 2024 |
| T32HL098040 | TRAINING PROGRAM IN LUNG BIOLOGY AND DISEASE | 1 | 2024 |
| T35HL007690 | Short Term Biomedical Research Training Program for Students | 1 | 2024 |
| U01AI136780 | Extended follow-up of randomized participants in the INSIGHT START trial | 1 | 2024 |
| U01CA238728 | Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment | 1 | 2024 |
| U01CA244101 | Defining bone ecosystem effects on metastatic prostate cancer evolution and treatment response using an integrated mathematical modeling approach | 1 | 2024 |
| U19AI149504 | (Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV | 1 | 2024 |
| U19CA203654 | Integrative Analysis of Lung Cancer Etiology and Risk | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=25